Q&A with Immunomic’s Teri Heiland, PhD What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy September 25, 2018 Teri Heiland, Ph.D. is the Senior Vice President of Research and Development, and Co-founder, at Immunomic Therapeutics, Inc., a clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. [….]
Presented by the Maryland Tech Council, Bio+Tech18 reflects the changing landscape where life science and technology converge by bringing together more than 400 professionals in both fields so that they may meet and forge new partnerships that will lead to great new discoveries. In its third year, the Bio+Tech18 Conference will continue to bring together [….]
BioBuzz with Immunomic Therapeutics Join us for this BioBuzz event and meet this year’s ‘Buzz of BIO’ winner and Annual BioBuzz Sponsor, Immunomic Therapeutics (ITI), at Bar Louie in Rockville on September 13th. Come out and get to know the team behind the company that is receiving such widespread industry attention for the recent evolution of [….]
Path to World Vaccine Conference was through ‘Vaccine Alley’ this year More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most recognized finalists at this year’s Vaccine Industry Excellence (ViE) Awards in Washington, DC at the World Vaccine Conference. In fact, [….]
